https://www.selleckchem.com/products/prgl493.html
There is no standard treatment for marginally resectable soft tissue sarcomas (STSs) of the extremities and trunk wall, and current approaches produce unsatisfactory results. We hypothesized that the combination of doxorubicin-ifosfamide (AI) chemotherapy and 5 × 5 Gy hypofractionated radiotherapy can generate a higher ratio of limb-sparing or conservative surgeries with negative microscopic margins (R and acceptable treatment toxicity. We conducted a single-arm prospective clinical trial. Treatment combined 1 cycle of AI with subsequ
Curtir
Comentario
Compartilhar
